Open original FDA record ↗Recall record
- FDA identifier
- Z-2167-2017
- Company in FDA record
- Randox Laboratories
- FDA classification date
- May 26, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
According to Randox Laboratories an investigation indicates a labelling error for 2 of the test methods listed for quantification of Total Protein (urine). The values for the mean of all instruments are incorrect by a factor of 10. Instrument specific values are correct. This does not affect the performance or stability claims of the product. As control results will be outside of the quoted range this may result in a delay in reporting the sample test results. However as the correct instrument specific means are also included in the value sheet this delay is unlikely. Customers have been referred to their Medical Director for further advice
Source facts
- Action
- Randox Laboratories will contact Customers directly by e-mail and will be followed up with once every 2 weeks over a period of 6 weeks. There are no plans in place to follow up with customers after the 6 week period. For further questions, please call (304) 728-2890.
- Initiated
- 2017-04-27
- Root cause
- Error in labeling
- Terminated
- 2017-08-14
- Distribution
- Worldwide Distribution - US Distribution to Puerto Rico and to the countries of : Canada Kuwait Chile Poland China Romania France Saudi Arabia Guatemala Slovenia Iran UAE India UK Italy Uruguay Iraq
- Recall number
- Z-2167-2017
- Recall status
- Terminated
- CDRH record ID
- 155040
- FDA classified
- 2017-05-26
- Recall event number
- 77152